Literature DB >> 3368068

Pharmacotherapy for aphasia.

M L Albert1, D L Bachman, A Morgan, N Helm-Estabrooks.   

Abstract

Selected features of aphasia may reflect disruption of specific neurotransmitter systems. Pharmacotherapy focused on these aphasic symptoms may improve language performance following stroke. We attempted to restore speech fluency in a patient with long-standing transcortical motor aphasia by treating his symptoms of hesitancy and impaired initiation of speech with bromocriptine. During therapy his language performance improved substantially, due to reduced latency of response, decreased paraphasias, and increased naming ability. After cessation of drug therapy his language returned to baseline.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368068     DOI: 10.1212/wnl.38.6.877

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  [Present status and future possibilities of adjuvant pharmacotherapy for aphasia].

Authors:  C Korsukewitz; C Breitenstein; M Schomacher; S Knecht
Journal:  Nervenarzt       Date:  2006-04       Impact factor: 1.214

2.  Treating organic abulia with bromocriptine and lisuride: four case studies.

Authors:  K Barrett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

Review 3.  Pharmacological treatment for aphasia following stroke.

Authors:  J Greener; P Enderby; R Whurr
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 4.  Poststroke aphasia : epidemiology, pathophysiology and treatment.

Authors:  Marcelo L Berthier
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Neuroscience insights improve neurorehabilitation of poststroke aphasia.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller
Journal:  Nat Rev Neurol       Date:  2011-02       Impact factor: 42.937

6.  Frontotemporal dementia and primary progressive aphasia: an update.

Authors:  Howard S Kirshner
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

7.  Thalamocortical diaschisis: positron emission tomography in humans.

Authors:  J C Baron; M Levasseur; B Mazoyer; F Legault-Demare; F Mauguière; S Pappata; P Jedynak; P Derome; J Cambier; S Tran-Dinh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

Review 8.  Drug therapy of post-stroke aphasia: a review of current evidence.

Authors:  Marcelo L Berthier; Friedemann Pulvermüller; Guadalupe Dávila; Natalia García Casares; Antonio Gutiérrez
Journal:  Neuropsychol Rev       Date:  2011-08-16       Impact factor: 7.444

9.  Impaired cognition and attention in adults: pharmacological management strategies.

Authors:  Hervé Allain; Yvette Akwa; Lucette Lacomblez; Alain Lieury; Danièle Bentué-Ferrer
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

10.  Aphasia therapy on a neuroscience basis.

Authors:  Friedemann Pulvermüller; Marcelo L Berthier
Journal:  Aphasiology       Date:  2008-05-21       Impact factor: 2.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.